Global and North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Status and Future Forecast 2013-2023

August 2018 | 130 pages | ID: G29F6CDCC92EN
99Strategy

Abstracts

SUMMARY

Key Content of Chapters (Including and can be customized)

Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Region
Part 3:
North America Market by company, Type, Application & Region
Part 4-6:
Key Regions of North America Market by Type, Application
Part 7:
Company information, Sales, Cost, Margin etc.
Part 8:
Conclusion

Market Segment as follows:

By Region

• Global (North America, Europe, Asia etc.)
• North America (United States, Canada, Mexico)

Key Companies

• Achelios Therapeutics Inc
• Advinus Therapeutics Ltd
• Apollo Endosurgery Inc
• Aptinyx Inc
• Asahi Kasei Pharma Corp
• Can-Fite BioPharma Ltd
• Celgene Corp
• DermaXon LLC
• Eisai
• Immune Pharmaceuticals Inc
• INSYS Therapeutics Inc
• Kineta Inc
• KPI Therapeutics Inc
• Krenitsky Pharmaceuticals Inc
• MAKScientific LLC
• Metys Pharmaceuticals AG
• Midatech Pharma US Inc
• Mundipharma International Ltd
• Nemus Bioscience Inc
• Neurocentrx Pharma Ltd
• Panacea Pharmaceuticals Inc
• PeriphaGen Inc
• PharmatrophiX Inc
• PledPharma AB
• Sova Pharmaceuticals Inc
• Virobay Inc
• WEX Pharmaceuticals Inc

Market by Type

• APX-3330
• BR-297
• Cannabidiol
• Dimiracetam
• Others

Market by Application

• Clinic
• Hospital
• Others

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 Achelios Therapeutics Inc
7.2 Advinus Therapeutics Ltd
7.3 Apollo Endosurgery Inc
7.4 Aptinyx Inc
7.5 Asahi Kasei Pharma Corp
7.6 Can-Fite BioPharma Ltd
7.7 Celgene Corp
7.8 DermaXon LLC
7.9 Eisai
7.10 Immune Pharmaceuticals Inc
7.11 INSYS Therapeutics Inc
7.12 Kineta Inc
7.13 KPI Therapeutics Inc
7.14 Krenitsky Pharmaceuticals Inc
7.15 MAKScientific LLC
7.16 Metys Pharmaceuticals AG
7.17 Midatech Pharma US Inc
7.18 Mundipharma International Ltd
7.19 Nemus Bioscience Inc
7.20 Neurocentrx Pharma Ltd
7.21 Panacea Pharmaceuticals Inc
7.22 PeriphaGen Inc
7.23 PharmatrophiX Inc
7.24 PledPharma AB
7.25 Sova Pharmaceuticals Inc
7.26 Virobay Inc
7.27 WEX Pharmaceuticals Inc

PART 8 CONCLUSION

List Of Tables

LIST OF TABLES

Table Type of Chemotherapy Induced Peripheral Neuropathy Treatment
Table Application of Chemotherapy Induced Peripheral Neuropathy Treatment
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Region, 2013-2017 (Million USD)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Company, 2013-2017 (Million USD)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Million USD)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Million USD)
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market by Region, 2013-2017 (Million USD)
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market by Company, 2013-2017 (Million USD)
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Million USD)
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Million USD)
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Million USD)
Table United States Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Million USD)
Table United States Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Million USD)
Table Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Million USD)
Table Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Million USD)
Table Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Million USD)
Table Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Achelios Therapeutics Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Achelios Therapeutics Inc
Table Advinus Therapeutics Ltd Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Advinus Therapeutics Ltd
Table Apollo Endosurgery Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Apollo Endosurgery Inc
Table Aptinyx Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Aptinyx Inc
Table Asahi Kasei Pharma Corp Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Asahi Kasei Pharma Corp
Table Can-Fite BioPharma Ltd Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Can-Fite BioPharma Ltd
Table Celgene Corp Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Celgene Corp
Table DermaXon LLC Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of DermaXon LLC
Table Eisai Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Eisai
Table Immune Pharmaceuticals Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Immune Pharmaceuticals Inc
Table INSYS Therapeutics Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of INSYS Therapeutics Inc
Table Kineta Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Kineta Inc
Table KPI Therapeutics Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of KPI Therapeutics Inc
Table Krenitsky Pharmaceuticals Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Krenitsky Pharmaceuticals Inc
Table MAKScientific LLC Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of MAKScientific LLC
Table Metys Pharmaceuticals AG Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Metys Pharmaceuticals AG
Table Midatech Pharma US Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Midatech Pharma US Inc
Table Mundipharma International Ltd Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Mundipharma International Ltd
Table Nemus Bioscience Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Nemus Bioscience Inc
Table Neurocentrx Pharma Ltd Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Neurocentrx Pharma Ltd
Table Panacea Pharmaceuticals Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Panacea Pharmaceuticals Inc
Table PeriphaGen Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of PeriphaGen Inc
Table PharmatrophiX Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of PharmatrophiX Inc
Table PledPharma AB Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of PledPharma AB
Table Sova Pharmaceuticals Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Sova Pharmaceuticals Inc
Table Virobay Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of Virobay Inc
Table WEX Pharmaceuticals Inc Information
Table Chemotherapy Induced Peripheral Neuropathy Treatment Sales, Cost, Margin of WEX Pharmaceuticals Inc

List Of Figures

LIST OF FIGURES

Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2018
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2018
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Region in 2018
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Region in 2018
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Region in 2017 (Million USD)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Region in 2017 (Volume)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Company in 2017 (Million USD)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Company in 2017 (Volume)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Million USD)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Volume)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Million USD)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Volume)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Million USD)
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Volume)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Region in 2017 (Million USD)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Region in 2017 (Volume)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Company in 2017 (Million USD)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Company in 2017 (Volume)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Million USD)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Volume)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Million USD)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Volume)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Million USD)
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Volume)
Figure United States Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Million USD)
Figure United States Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Volume)
Figure United States Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Million USD)
Figure United States Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Volume)
Figure United States Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Million USD)
Figure United States Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Volume)
Figure Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Million USD)
Figure Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Volume)
Figure Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Million USD)
Figure Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Volume)
Figure Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Million USD)
Figure Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Volume)
Figure Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Million USD)
Figure Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Type in 2017 (Volume)
Figure Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Million USD)
Figure Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market Share by Application in 2017 (Volume)
Figure Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Million USD)
Figure Mexico Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast, 2018-2023 (Volume)